Page last updated: 2024-08-24

meglumine antimoniate and Pancreatitis

meglumine antimoniate has been researched along with Pancreatitis in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (53.85)	18.2507
2000's	5 (38.46)	29.6817
2010's	1 (7.69)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bóia, MN; Brustoloni, YM; Cunha, RV; Dorval, ME; Fernandes, TD; Oliveira, AL	1
Balasegaram, M; Hailu, A; Hailu, W; Hurissa, Z; Omollo, R; Tafes, H; Weldegebreal, T; Yifru, S	1
Aste, G; Boari, A; Di Tommaso, M; Steiner, JM; Williams, DA	1
Berman, JD; Franke, ED; Gasser, RA; Grögl, M; Magill, AJ; Oster, CN	1
Cortés, E; Cucurull, E; de Otero, J; Ocaña, I; Pahissa, A; Ribera, E	1
González-Lahoz, JM; Laguna, F; Soriano, V	1
Barthet, M; Berland, Y; Bernard, JC; Brunet, P; Dussol, B; Jouglard, J; Rodor, F; Sahel, J	1
de Lalla, F; Franzetti, M; Gradoni, L; Pellizzer, G; Stecca, C; Vespignani, M	1
Boix, V; Massa, B; Pérez-Mateo, M; Portilla, J; Torrús, D	1
Corzo, JE; de la Rosa, R; Delgado, J; González-Moreno, MP; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A	1
González Lahoz, J; Laguna, F; Valencia, ME	1
Márquez, M; Rivero, A; Santos, J	1
Bakirtaç, A; Kara, C; Kuyucu, N; Teziç, T	1

Reviews

1 review(s) available for meglumine antimoniate and Pancreatitis

Article	Year
[Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection]. Anales de medicina interna (Madrid, Spain : 1984), 2000, Volume: 17, Issue:10 Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Fatal Outcome; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Substance Abuse, Intravenous	2000

Article

Year

[Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].

Anales de medicina interna (Madrid, Spain : 1984), 2000, Volume: 17, Issue:10

Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Fatal Outcome; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Substance Abuse, Intravenous

2000

Other Studies

12 other study(ies) available for meglumine antimoniate and Pancreatitis

Article	Year
Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil. Tropical doctor, 2009, Volume: 39, Issue:3 Topics: Adolescent; Adult; Antiprotozoal Agents; Female; Heart; Humans; Leishmaniasis, Visceral; Liver Failure; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancreatitis; Renal Insufficiency	2009
Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2010, Volume: 104, Issue:11 Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Comorbidity; Ethiopia; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Renal Insufficiency; Treatment Outcome; Young Adult	2010
Pancreatitis associated with N-methyl-glucamine therapy in a dog with leishmaniasis. Veterinary research communications, 2005, Volume: 29 Suppl 2 Topics: Acute Disease; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis	2005
Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:1 Topics: Adult; Amylases; Antimony Sodium Gluconate; Antiprotozoal Agents; District of Columbia; Humans; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Lipase; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancreatitis; Peru; Prospective Studies	1994
[Acute pancreatitis due to antimonials in patients with visceral leishmaniasis and HIV infection]. Medicina clinica, 1995, Apr-22, Volume: 104, Issue:15 Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Enzyme Tests; Female; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Recurrence	1995
Misdiagnosis of pancreatitis in patients receiving treatment with pentavalent antimonial agents. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 19, Issue:5 Topics: Diagnostic Errors; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Prospective Studies	1994
[Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)]. Gastroenterologie clinique et biologique, 1994, Volume: 18, Issue:1 Topics: Acute Disease; Adult; Animals; Antiprotozoal Agents; Female; Humans; Immune Tolerance; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis	1994
Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 16, Issue:5 Topics: Acute Disease; Adult; Antimony; Antiprotozoal Agents; Female; Ghana; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis	1993
Meglumine antimoniate-induced pancreatitis. The American journal of gastroenterology, 1996, Volume: 91, Issue:4 Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis	1996
High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients. The American journal of tropical medicine and hygiene, 1999, Volume: 61, Issue:5 Topics: Adult; Amylases; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Creatinine; Female; HIV Infections; HIV-1; Humans; Leishmania infantum; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Recurrence; Retrospective Studies; Vomiting	1999
[Nephrotic syndrome and acute pancreatitis related to glucantime administration]. Anales de medicina interna (Madrid, Spain : 1984), 2000, Volume: 17, Issue:1 Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Nephrotic Syndrome; Organometallic Compounds; Pancreatitis	2000
Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate. The Pediatric infectious disease journal, 2001, Volume: 20, Issue:4 Topics: Acute Disease; Allopurinol; Antiprotozoal Agents; Child, Preschool; Humans; Ketoconazole; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis	2001